First-Time Disclosures

First-Time Disclosures

Breakthroughs from ACS Fall 2025: 13 First-Time Drug Structure Disclosures Across 6 Major Disease Areas

ACS Fall 2025 revealed 13 first-time clinical candidates across infectious disease, immunology, cardiometabolic, neurodegeneration, and oncology. This post reviews their targets, modalities, and competitive positioning—including China-based pipelines.